Rate My Professor Joy Wolfram

Associate Professor Joy Wolfram holds joint appointments in the School of Chemical Engineering and the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland. She serves as Research Director of the Herston Biofabrication Institute, a partnership with Metro North Health. Wolfram earned a Bachelor’s degree and a Master’s degree (coursework) from the University of Helsinki and a Doctor of Philosophy from the University of the Chinese Academy of Science. Her research program centers on extracellular vesicles, focusing on developing nanotechnology and cell product-based therapeutics for life-threatening diseases such as cardiovascular disease, kidney disease, and breast cancer. Key focus areas include improving extracellular vesicle isolation from human biofluids, designing hybrid drug delivery systems combining extracellular vesicles with synthetic components, and elucidating extracellular vesicles' roles in cancer immunoevasion and metastasis. The Wolfram Laboratory innovates in manufacturing, biological mechanisms, and drug loading of extracellular vesicles to create therapeutics that outperform conventional pharmaceuticals through versatile bioactive cargo.

Prior to her current roles, Wolfram chaired an education and outreach working group for the National Institutes of Health in the United States and served as Associate Program Director of the PhD Program in Regenerative Sciences at Mayo Clinic. She has received 49 awards from nine countries, including the 2016 Amgen Scholars Ten to Watch List, the 2019 Forbes 30 under 30 in Health Care for the United States and Canada, a 2019 shortlist for the Nature Research Award for Inspiring Science, and the 2021 Finnish Expatriate of the Year. Her work has yielded over 100 publications in high-impact journals such as Nature Nanotechnology, with more than 21,700 citations. Notable publications include 'Entry and exit of extracellular vesicles to and from the blood circulation' (2023, Nature Nanotechnology), 'Extracellular Vesicles and B Cell Interactions: B-Side Track or Greatest Hit?' (2025, ACS Nano), and 'Lipoprotein Association Fluorometry (LAF) as a semi‐quantitative characterization tool to assess extracellular vesicle‐lipoprotein binding' (2025, Journal of Extracellular Vesicles). Wolfram has collaborated with 160 universities and industry partners across 45 countries, delivered over 100 invited and keynote talks, and engages in community outreach as a TED speaker. She ranks in the top 1 percent of researchers in extracellular vesicles, cancer, drug delivery, biology/biochemistry, and pharmacology/toxicology.